Search results

1. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t…

Principal investigator: dr hab. Damian Nestor Plażuk

Uniwersytet Łódzki

Call: OPUS 27, Panel: NZ7

2. Development of new implantable drug forms, biodegradable nanofibers containing selected betulin derivatives in order to …

Principal investigator: prof. Janusz Edward Kasperczyk

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

Call: OPUS 21, Panel: NZ7

3. Chemical effects in targeted drug delivery: The roles of anticancer drugs, carriers and conjugates on biomimetic membran…

Principal investigator: dr Dorota Maria Nieciecka

Uniwersytet Warszawski, Wydział Chemii

Call: SONATA 12, Panel: ST4

4. Effect of dietary modulation of RAGE/AGE axis on prostatic neuroendocrine differentiation and the efficacy of anticancer…

Principal investigator: dr Wawrzyniec Dobrucki

Gdański Uniwersytet Medyczny

Call: OPUS 29, Panel: NZ7

5. Potential pharmacological strategies aimed at alleviating cognitive dysfunctions accompanying oncological therapy while …

Principal investigator: dr hab. Joanna Monika Wierońska

Instytut Farmakologii PAN

Call: OPUS 26, Panel: NZ5

6. Molecular and physiological mechanisms of vanadium influence on the uptake of iodates and iodosalicylates by lettuce and…

Principal investigator: prof. Sylwester Marcin Smoleń

Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie, Wydział Biotechnologii i Ogrodnictwa

Call: OPUS 13, Panel: NZ9

7. Factors influencing effective transport of anticancer drugs through cell membranes studied on the example of the interac…

Principal investigator: dr Dorota Matyszewska

Uniwersytet Warszawski, Wydział Chemii

Call: SONATA 12, Panel: ST4

8. Effectiveness of anticancer activity of DMU-214 (3'-hydroxy-3,4,5,4'-tetrametoxystilbene) in personalized treatment for …

Principal investigator: dr hab. Hanna Helena Piotrowska-Kempisty

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: SONATA 12, Panel: NZ7

9. Analysis of the effectiveness of anticancer activity of tyrosine kinase inhibitors combined with nanoparticles in in vit…

Principal investigator: dr Natalia Piergies

Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

Call: SONATA 11, Panel: ST4

10. Hydrogel microspheres containing dextran-based nanoparticles. Study on targeting effect in novel anticancer drug deliver…

Principal investigator: Aleksandra Anna Kulikowska

Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

Call: PRELUDIUM 7, Panel: NZ5

11. Effects of receptor action of L- and D-Lactate on cervical cancer cells. Lactate modulation of cell DNA repair response …

Principal investigator: dr Waldemar Wagner

Instytut Biologii Medycznej PAN

Call: OPUS 2, Panel: NZ4

12. The examination of isothiocyanates influence on cytotoxic and cytostatic effects of 5-fluorouracil in cancer cell lines …

Principal investigator: Małgorzata Milczarek

Narodowy Instytut Leków

Call: PRELUDIUM 3, Panel: NZ5

13. Cellular mechanisms and effects in vivo of selective lactate dehydrogenase A inhibitors in experimental models of mesoth…

Principal investigator: prof. Ryszard Tomasz Smoleński

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: OPUS 16, Panel: NZ7

14. Effect of egg's yolk fatty acids enriched in conjugated linoleic acids (CLA) on apoptosis - an investigation of pro-apop…

Principal investigator: dr Dominik Domagała

Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie, Wydział Technologii Żywności

Call: PRELUDIUM 11, Panel: NZ9

15. Synthesis of new glutamate receptors antagonists and extensive investigation of their effect on tumor cells in the prese…

Principal investigator: prof. Maria Wanda Bretner

Politechnika Warszawska, Wydział Chemiczny

Call: OPUS 9, Panel: ST5

Projects search